Skip to main content

Table 1 The antropometric, clinical and metabolic data of the study group

From: The role of mediastinal adipose tissue 11β-hydroxysteroid d ehydrogenase type 1 and glucocorticoid expression in the development of coronary atherosclerosis in obese patients with ischemic heart disease

  Obese CAD group (n = 31) Controls (n = 16) p value
Antropometric characteristics    
Age (years) 57.4 ± 9.1 58.1 ±10.4 NS
Female–male (%) 66-34 51-49 NS
BMI (kg/m 2 ) 33.6 ± 3.1 30.0 ±5.2 NS
Waist/hip ratio 1.1 ± 0.0 0.8 ± 0.1 NS
Risk factors    
Smoking (%) 44 66 0.004
Family history of CAD (%) 62 25 0.0001
Metabolic characteristics and indices    
SBP (mm Hg) 135.9 ± 19.4 129.5 ± 30.2 NS
DBP (mm Hg) 78.5 ± 8.9 77.3 ± 8.1 NS
Total-cholesterol (mg/dl) 196.1 ± 31.9 200.1 ± 31.4 NS
HDL-cholesterol (mg/dl) 41.2 ± 9.0 45 ± 11.9 NS
LDL-cholesterol (mg/dl) 111.5 ± 19.0 142.4 ± 29.7 0.041
Triglycerides (mg/dl) 191.0 ± 21.5 201.1 ± 24.1 NS
Cortisol (μg/dl) 13.1 ± 4.5 8.2 ± 3.1 0.006
HOMA-IR 3.1 ± 1.6 1.9 ± 1.0 0.005
C-peptid (ng/ml) 2.6 ± 1.1 3.2 ± 1.2 NS
Epicardial fat (cm 3 ) 8.8 ± 5.1 6.0 ± 2.5 0.001
Subcutaneous fat (cm 3 ) 138.8 ± 44.1 133.1 ± 39.1 NS
  1. Values are represented as mean ± SD, or as percentages. SD: Standard deviation, BMI: Body mass index, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, HDL: High density lipoprotein, LDL: Low density lipoprotein, HOMA-IR: Homeostasis Model of Assessment - Insulin Resistance. Groups were compared with Mann–Whitney U test for the variables.